2026 # 366 Follow-Up Care for Children Prescribed ADHD Medication

2026 COLLECTION TYPE:

MERIT-BASED INCENTIVE PAYMENT SYSTEM (MIPS) CLINICAL QUALITY MEASURE (CQM)

‌MEASURE TYPE: Process

Description:

Percentage of children 6-12 years of age and newly prescribed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported.

a. Percentage of children who had one follow-up visit with a practitioner with prescribing authority during the 30-Day Initiation Phase.

b. Percentage of children who remained on ADHD medication for at least 210 treatment days and who, in addition to the visit in the Initiation Phase, had at least two additional follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended

Denominator:

Equals Initial Population

Denominator Exclusion:

Exclude patients who are in hospice care for any part of the measurement period.

Exclude patients diagnosed with narcolepsy at any point in their history or during the measurement period.

Numerator:

Numerator 1: Patients who had at least one visit with a practitioner with prescribing authority during the Initiation Phase.

Numerator 2: Patients who had at least one visit with a practitioner with prescribing authority during the Initiation Phase, and at least two follow-up visits on different dates of service during th

Telehealth Eligible: Yes